New York State Common Retirement Fund Coherus Bio Sciences, Inc. Transaction History
New York State Common Retirement Fund
- $76.2 Billion
- Q2 2024
A detailed history of New York State Common Retirement Fund transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 111,178 shares of CHRS stock, worth $115,625. This represents 0.0% of its overall portfolio holdings.
Number of Shares
111,178
Previous 111,107
0.06%
Holding current value
$115,625
Previous $266,000
27.82%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding CHRS
# of Institutions
143Shares Held
82.7MCall Options Held
79.1KPut Options Held
100K-
Black Rock Inc. New York, NY11.8MShares$12.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.6MShares$11 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.4MShares$10.8 Million0.53% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U05.82MShares$6.05 Million0.05% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY3.04MShares$3.16 Million0.3% of portfolio
About Coherus BioSciences, Inc.
- Ticker CHRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,724,600
- Market Cap $80.8M
- Description
- Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...